Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

56.2K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

10.5K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.5K
Enzyme Inhibition01:30

Enzyme Inhibition

88.8K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
88.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.3K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
The Electron Transport Chain01:30

The Electron Transport Chain

18.8K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
18.8K
Enzymes02:34

Enzymes

88.6K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
88.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dendritic cell-specific hypoxia-inducible factor-1α deficiency protects mice from recurrent retroviral infection.

Experimental physiology·2026
Same author

M<sup>1</sup>ündlich - S(t)imulation of competency-oriented learning in physiology.

BMC medical education·2026
Same author

Cardioprotective effects of prolyl hydroxylase inhibitors during reperfusion in myocardial infarction: A study using cardiosphere-derived cells.

Experimental physiology·2026
Same author

Just a little prick: careful cell contacts enabled by ceramic nanostraws.

Pflugers Archiv : European journal of physiology·2026
Same author

Resetting of the Human Circadian Melatonin Rhythm by Ambient Hypoxia.

Journal of pineal research·2025
Same author

Primary cilia as antennas for oxygen.

American journal of physiology. Cell physiology·2024

Related Experiment Video

Updated: Nov 20, 2025

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition
07:42

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition

Published on: September 3, 2016

15.2K

Ways into Understanding HIF Inhibition.

Tina Schönberger1, Joachim Fandrey1, Katrin Prost-Fingerle1

  • 1Institute of Physiology, University of Duisburg-Essen, 45147 Essen, Germany.

Cancers
|January 20, 2021
PubMed
Summary

Inhibiting hypoxia-inducible factors (HIFs) is crucial for cancer treatment. Understanding how HIF inhibitors work is key to developing effective anticancer drugs and ensuring patient safety.

Keywords:
FRETHIFPHDcancerhypoxiahypoxia-inducible factorinhibitorpVHLvisualization

More Related Videos

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.8K
A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

10.1K

Related Experiment Videos

Last Updated: Nov 20, 2025

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition
07:42

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition

Published on: September 3, 2016

15.2K
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.8K
A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

10.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Hypoxia, or low oxygen, is a hallmark of tumor microenvironments.
  • Cancer cells activate hypoxia-inducible factors (HIFs) to survive and proliferate under hypoxic conditions.
  • HIF pathway dysregulation is implicated in numerous solid and liquid cancers.

Purpose of the Study:

  • To review current classes of HIF pathway inhibitors.
  • To explore in vitro and in vivo techniques for understanding inhibitor mechanisms.
  • To highlight the importance of elucidating inhibitor modes of action for clinical application.

Main Methods:

  • Review of existing literature on HIF inhibitors.
  • Discussion of various in vitro and in vivo methodologies.
  • Exploration of advanced imaging techniques (luminescent, fluorescent, nanobodies) and chromatin immunoprecipitation.

Main Results:

  • Several drug candidates targeting HIF pathway interactions and transcription are in development, with some in clinical trials.
  • Open questions persist regarding the precise mechanisms of action for many HIF inhibitors.
  • Novel imaging and molecular techniques offer potential to clarify these mechanisms.

Conclusions:

  • Understanding the specific mechanisms of HIF inhibitors is essential for their successful clinical translation.
  • Elucidating inhibitor action is critical for optimizing efficacy and ensuring the safety of novel anticancer therapies.
  • Further research employing advanced techniques will accelerate the development of targeted HIF-inhibiting cancer treatments.